Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients.

@article{Ikawa2013DetectionOP,
  title={Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients.},
  author={Masamichi Ikawa and Makoto Yoneda and Tomoko Muramatsu and Akiko Matsunaga and Tetsuya Tsujikawa and Tatsuya Yamamoto and Nobuyuki Kosaka and Kazuyuki Kinoshita and Osamu Yamamura and Tadanori Hamano and Yasunari Nakamoto and Hirohiko Kimura},
  journal={Mitochondrion},
  year={2013},
  volume={13 6},
  pages={676-80}
}
In stroke-like episodes (SEs) of patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS), the detection of preclinically latent lesions is a challenge. We report regional cerebral hyperperfusion observed on arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI) in the preclinical phase more than 3 months before the clinical onset of SEs in 3 MELAS patients. These hyperperfused areas were not detected by conventional MRI in the… CONTINUE READING

3 Figures & Tables

Connections & Topics

Mentioned Connections BETA
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
MyopathyManifestation ofMELAS Syndrome
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
In stroke - like episodes ( SEs ) of patients with mitochondrial myopathy , encephalopathy , lactic acidosis and stroke - like episodes ( MELAS ) , the detection of preclinically latent lesions is a challenge .
All Topics